Register for email alerts and news feeds:
This journal | BMJ Group
rss
Drug and Therapeutics Bulletin 1999;37:71-72; doi:10.1136/dtb.1999.37971
Copyright © 1999 by the BMJ Publishing Group Ltd.

Hyaluronan or hylans for knee osteoarthritis?

Relevant BNF section: 10.1

In joints affected by osteoarthritis, the synovial fluid's capacity to lubricate and to absorb shock are typically reduced. These changes are partly due to a reduction in the size and concentration of hyaluronic acid (hyaluronan1) molecules naturally present in synovial fluid. A new approach in the management of osteoarthritis of the knee is to inject hyaluronan or derivatives of this molecule (hylans) into the joint. We consider the place of two preparations: {blacktriangledown}Hyalgan and Synvisc.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for email alerts

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Coming soon!

The DTB archive back to 1962, volume 1, issue 1 will soon be available.